Inhibition of primary ciliogenesis enhances efficacy of EGFR‑TKIs against non‑small cell lung cancer cells
Oncology Reports · 2025
DOI: 10.3892/or.2025.9035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Liangliang Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The 940th Hospital of Joint Logistics Support force of Chinese People's Liberation Army, Lanzhou, Gansu 730050, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cilia, Protein Kinase Inhibitors. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The 940th Hospital of Joint Logistics Support force of Chinese People's Liberation Army, Lanzhou, Gansu 730050, P.R. China.
- NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor & Clinical Lab, Gansu Provincial Hospital, Lanzhou, Gansu 730000, P.R. China.
- Key Laboratory of Space Radiobiology of Gansu, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, Gansu 73000, P.R. China.
- School of Basic Medical Sciences & School of Public Health, Gansu University of Chinese Medicine, Lanzhou, Gansu 730000, P.R. China.
Zitieren
APA
Jin, L., Wei, L., Hua, J., Zhang, R., Chen, J., He, J., & Yang, Y. (2025). Inhibition of primary ciliogenesis enhances efficacy of EGFR‑TKIs against non‑small cell lung cancer cells. Oncology Reports. https://doi.org/10.3892/or.2025.9035
Vancouver
Jin L, Wei L, Hua J, Zhang R, Chen J, He J, et al. Inhibition of primary ciliogenesis enhances efficacy of EGFR‑TKIs against non‑small cell lung cancer cells. Oncology Reports. 2025. doi:10.3892/or.2025.9035
BibTeX
@article{Jin2025,
author = {Jin, Liangliang and Wei, Li and Hua, Junrui and Zhang, Rong and Chen, Jiaxin and He, Jinpeng and Yang, Yanli},
title = {Inhibition of primary ciliogenesis enhances efficacy of EGFR‑TKIs against non‑small cell lung cancer cells},
journal = {Oncology Reports},
year = {2025},
doi = {10.3892/or.2025.9035}
}
EUVIMED